Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
The CCL5/CCR5 Axis in Cancer Progression
View through CrossRef
Tumor cells can “hijack” chemokine networks to support tumor progression. In this context, the C-C chemokine ligand 5/C-C chemokine receptor type 5 (CCL5/CCR5) axis is gaining increasing attention, since abnormal expression and activity of CCL5 and its receptor CCR5 have been found in hematological malignancies and solid tumors. Numerous preclinical in vitro and in vivo studies have shown a key role of the CCL5/CCR5 axis in cancer, and thus provided the rationale for clinical trials using the repurposed drug maraviroc, a CCR5 antagonist used to treat HIV/AIDS. This review summarizes current knowledge on the role of the CCL5/CCR5 axis in cancer. First, it describes the involvement of the CCL5/CCR5 axis in cancer progression, including autocrine and paracrine tumor growth, ECM (extracellular matrix) remodeling and migration, cancer stem cell expansion, DNA damage repair, metabolic reprogramming, and angiogenesis. Then, it focuses on individual hematological and solid tumors in which CCL5 and CCR5 have been studied preclinically. Finally, it discusses clinical trials of strategies to counteract the CCL5/CCR5 axis in different cancers using maraviroc or therapeutic monoclonal antibodies.
Title: The CCL5/CCR5 Axis in Cancer Progression
Description:
Tumor cells can “hijack” chemokine networks to support tumor progression.
In this context, the C-C chemokine ligand 5/C-C chemokine receptor type 5 (CCL5/CCR5) axis is gaining increasing attention, since abnormal expression and activity of CCL5 and its receptor CCR5 have been found in hematological malignancies and solid tumors.
Numerous preclinical in vitro and in vivo studies have shown a key role of the CCL5/CCR5 axis in cancer, and thus provided the rationale for clinical trials using the repurposed drug maraviroc, a CCR5 antagonist used to treat HIV/AIDS.
This review summarizes current knowledge on the role of the CCL5/CCR5 axis in cancer.
First, it describes the involvement of the CCL5/CCR5 axis in cancer progression, including autocrine and paracrine tumor growth, ECM (extracellular matrix) remodeling and migration, cancer stem cell expansion, DNA damage repair, metabolic reprogramming, and angiogenesis.
Then, it focuses on individual hematological and solid tumors in which CCL5 and CCR5 have been studied preclinically.
Finally, it discusses clinical trials of strategies to counteract the CCL5/CCR5 axis in different cancers using maraviroc or therapeutic monoclonal antibodies.
Related Results
Exploring CCR5 + T regulatory cell subset dysfunction in type 1 diabetes patients: implications for immune regulation
Exploring CCR5 + T regulatory cell subset dysfunction in type 1 diabetes patients: implications for immune regulation
AbstractT regulatory lymphocytes (Treg) expressing CCR5 exhibit strong suppression activity in various autoimmune disorders. However, there remains a lack of comprehensive understa...
CCL5: a novel biomarker in a diagnostic model for bone metastasis in prostate cancer
CCL5: a novel biomarker in a diagnostic model for bone metastasis in prostate cancer
Abstract
Treating metastatic prostate cancer and bone metastasis is challenging, impacting both life quality and survival. CCL5 is known to promote prostate-cancer stem-cel...
Identification of CCR5 Δ32 Allele in Different Ethnic Groups of Nepal
Identification of CCR5 Δ32 Allele in Different Ethnic Groups of Nepal
The chemokine receptor CCR5 exhibits an important role for the CD-4 mediated entry of HIV-1. Previous studies revealed that Δ32 mutation on the CCR5 gene results in truncated prote...
Targeting SIRT7 shape an immune-activated microenvironment by both promoting CCL5-induced TILs infiltration and decreasing PD-L1 expression
Targeting SIRT7 shape an immune-activated microenvironment by both promoting CCL5-induced TILs infiltration and decreasing PD-L1 expression
Abstract
Background
Tumors adapt and survival under immune surveillance by manipulating various adaptive immune-repressive micr...
Impaired Macrophage Function and Enhanced T Cell-Dependent Immune Response in Mice Lacking CCR5, the Mouse Homologue of the Major HIV-1 Coreceptor
Impaired Macrophage Function and Enhanced T Cell-Dependent Immune Response in Mice Lacking CCR5, the Mouse Homologue of the Major HIV-1 Coreceptor
AbstractThe CC-chemokine receptor CCR5 has been shown to be the major coreceptor for HIV-1 entry into cells, and humans with homozygous mutation in the ccr5 gene are highly resista...
CCR5 Down-regulates Osteoclast Function in Orthodontic Tooth Movement
CCR5 Down-regulates Osteoclast Function in Orthodontic Tooth Movement
During orthodontic tooth movement, there is local production of chemokines and an influx of leukocytes into the periodontium. CCL5 plays an important role in osteoclast recruitment...
Analytical and Biological Considerations in the Measurement of Cell-Associated CCR5 and CXCR4 mRNA and Protein
Analytical and Biological Considerations in the Measurement of Cell-Associated CCR5 and CXCR4 mRNA and Protein
ABSTRACT
The accurate measurement of T cell-associated CC chemokine receptor type 5 (CCR5) and CXC chemokine receptor type 4 (CXCR4) expression, including expression of C...
CD8 chemokine receptors in chronic obstructive pulmonary disease
CD8 chemokine receptors in chronic obstructive pulmonary disease
SummaryIncreased lung CD8 cells and their expression of chemokine receptors CXCR3 and CCR5 have been previously reported in chronic obstructive pulmonary disease (COPD). Alteration...